Follow
M K Chaitanya Mannava
M K Chaitanya Mannava
Expert (Science & Technology) at Novartis, University of Hyderabad
Verified email at novartis.com - Homepage
Title
Cited by
Cited by
Year
A novel curcumin–artemisinin coamorphous solid: physical properties and pharmacokinetic profile
K Suresh, MKC Mannava, A Nangia
Rsc Advances 4 (102), 58357-58361, 2014
812014
Soluble salts and cocrystals of clotrimazole
S Mittapalli, MKC Mannava, UBR Khandavilli, S Allu, A Nangia
Crystal Growth & Design 15 (5), 2493-2504, 2015
702015
Entacapone: Improving aqueous solubility, diffusion permeability, and cocrystal stability with theophylline
MK Bommaka, MKC Mannava, K Suresh, A Gunnam, A Nangia
Crystal Growth & Design 18 (10), 6061-6069, 2018
632018
Enhanced bioavailability in the oxalate salt of the anti-tuberculosis drug ethionamide
MKC Mannava, K Suresh, A Nangia
Crystal Growth & Design 16 (3), 1591-1598, 2016
552016
Cocrystals and alloys of nitazoxanide: enhanced pharmacokinetics
K Suresh, MKC Mannava, A Nangia
Chemical communications 52 (22), 4223-4226, 2016
522016
Improved stability of tuberculosis drug fixed-dose combination using isoniazid-caffeic acid and vanillic acid cocrystal
S Battini, MKC Mannava, A Nangia
Journal of Pharmaceutical Sciences 107 (6), 1667-1679, 2018
462018
Enhanced solubility, permeability, and tabletability of nicorandil by salt and cocrystal formation
MKC Mannava, A Gunnam, A Lodagekar, NR Shastri, AK Nangia, ...
CrystEngComm 23 (1), 227-237, 2021
442021
Improving the dissolution rate of the anticancer drug dabrafenib
SK Rai, A Gunnam, MKC Mannava, AK Nangia
Crystal Growth & Design 20 (2), 1035-1046, 2020
402020
Curcumin-artemisinin coamorphous solid: Xenograft model preclinical study
MKC Mannava, K Suresh, M Kumar Bommaka, D Bhavani Konga, ...
Pharmaceutics 10 (1), 7, 2018
352018
Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation
A Lodagekar, RB Chavan, MKC Mannava, B Yadav, N Chella, AK Nangia, ...
European Journal of Pharmaceutical Sciences 139, 105048, 2019
282019
Cocrystals, salts, and supramolecular gels of nonsteroidal anti-inflammatory drug niflumic acid
S Mittapalli, MKC Mannava, R Sahoo, A Nangia
Crystal Growth & Design 19 (1), 219-230, 2018
282018
Naftopidil molecular salts with improved dissolution and permeation
MKC Mannava, R Dandela, S Tothadi, KA Solomon, AK Nangia
Crystal Growth & Design 20 (5), 3064-3076, 2020
242020
Role of hydrogen bonding in cocrystals and coamorphous solids: indapamide as a case study
S Allu, K Suresh, G Bolla, MKC Mannava, A Nangia
CrystEngComm 21 (13), 2043-2048, 2019
242019
Quantification of niclosamide polymorphic forms–A comparative study by Raman, NIR and MIR using chemometric techniques
V Bhavana, RB Chavan, MKC Mannava, A Nangia, NR Shastri
Talanta 199, 679-688, 2019
222019
Fluorobenzoic acid coformers to improve the solubility and permeability of the BCS class IV drug naftopidil
MKC Mannava, MK Bommaka, R Dandela, KA Solomon, AK Nangia
Chemical Communications 58 (37), 5582-5585, 2022
172022
Entacapone polymorphs: crystal structures, dissolution, permeability, and stability
MK Bommaka, MK Chaitanya Mannava, SK Rai, K Suresh, AK Nangia
Crystal Growth & Design 21 (10), 5573-5585, 2021
132021
Diffusion and Flux Improvement of Drugs through Complexation
MKC Mannava, A Garai, AK Nangia
Molecular Pharmaceutics 20 (5), 2293-2316, 2023
122023
Preclinical bioavailability–bioequivalence and toxico-kinetic profile of stable succinc acid cocrystal of temozolomide
E Sravani, MKC Mannava, D Kaur, BR Annapurna, RA Khan, K Suresh, ...
Current Science, 1097-1106, 2015
112015
Solubility and permeability enhancement of BCS class IV drug ribociclib through cocrystallization
MKC Mannava, A Garai, MK Bommaka, KA Solomon, AK Nangia
CrystEngComm 24 (45), 7915-7923, 2022
52022
The inhibitory effect of Curcumin-Artemisinin co-amorphous on Tau aggregation and Tau phosphorylation
T Dubey, SK Sonawane, MKC Mannava, AK Nangia, M Chandrashekar, ...
Colloids and Surfaces B: Biointerfaces 221, 112970, 2023
12023
The system can't perform the operation now. Try again later.
Articles 1–20